SKIN — Skinhealth Systems Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeSmall CapNeutral

Annual income statement for Skinhealth Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	260	366	398	334	301
Cost of Revenue
Gross Profit	179	249	193	210	204
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	300	392	529	369	303
Operating Profit	-39.9	-25.8	-131	-34.4	-2.7
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-381	45.3	-102	-29.6	-5.94
Provision for Income Taxes
Net Income After Taxes	-379	44.2	-100	-29.1	-9.52
Net Income Before Extraordinary Items
Net Income	-379	44.2	-100	-29.1	-9.52
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-379	44.2	-100	-29.1	-9.52
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3.71	0.298	-0.538	-0.263	-0.131